Precedent transactions are the valuation methodology that bakes in what an acquirer actually paid — control, synergies and a competitive process included. That makes them powerful and tricky: the multiples are real, but the context behind each deal is everything.
The questions below are drawn from our interview question bank, grouped by difficulty. Each shows the interviewer's phrasing plus a compressed model answer. The recurring follow-up is 'why is this set higher than your trading comps?' — practice that answer until it's automatic.
Why precedent transactions get tested
Transaction comps reveal whether you understand control premiums and synergies — the reasons deal multiples typically exceed trading multiples. That gap is a favorite follow-up.
They also test deal-selection judgment: recency, comparability of the target, and whether market conditions at the time of each deal still apply. A strong answer screens deals, it doesn't just list them.
Warm-up questions
Q: What is the 1-day premium in a premium paid analysis and how is it calculated?
A (summary): Premium paid analysis compares offer price with unaffected price, VWAP, and periods before rumors. For 1-day premium, I would calculate premium over 1-day, 30-day, and 90-day prices, always checking leakage and liquidity. Key points: Document data limitations and outlier treatment.
Q: How do you calculate the implied EV of an M&A transaction from the price paid per share? Which adjustments do you need to make in the bridge?
A (summary): Transaction multiples use prices paid in real deals, so they capture control, synergies, and M&A cycle timing. For deal value bridge, I would calculate transaction value including equity purchase price, assumed debt, and adjustments, divided by normalized EBITDA or revenue. Key points: Document data limitations and outlier treatment.
Core questions
Q: How do you determine the 'unaffected price' of a stock when there is market speculation weeks before the official announcement of the transaction?
A (summary): Premium paid analysis compares offer price with unaffected price, VWAP, and periods before rumors. For unaffected price, I would calculate premium over 1-day, 30-day, and 90-day prices, always checking leakage and liquidity. Key points: Document data limitations and outlier treatment.
Q: In a Brazilian OPA (tender offer) for change of control, the CVM requires the offered price to meet specific criteria. How does the premium paid analysis integrate with those regulatory requirements?
A (summary): Premium paid analysis compares offer price with unaffected price, VWAP, and periods before rumors. For Brazil OPA context, I would calculate premium over 1-day, 30-day, and 90-day prices, always checking leakage and liquidity. Key points: Document data limitations and outlier treatment.
Q: An acquisition rumor leaked 45 days before the announcement and the stock rose 18%. How do you determine the unaffected price to calculate the real premium paid in the transaction?
A (summary): Transaction multiples use prices paid in real deals, so they capture control, synergies, and M&A cycle timing. For rumor unaffected price, I would calculate transaction value including equity purchase price, assumed debt, and adjustments, divided by normalized EBITDA or revenue. Key points: Document data limitations and outlier treatment.
Q: Why do Precedent Transactions typically produce higher valuation multiples than Public Comps?
A (summary): Precedent Transactions reflect actual acquisition prices, which include a control premium — the extra amount a buyer must pay above the target's market price to gain full control of the business. Buyers pay this premium because controlling a business is more valuable than owning a minority stake: you can change strategy, replace management, realize synergies, and make operational improvements. Key points: Control premium = extra price paid above market value to acquire full control; Typical control premiums: 20–30% above unaffected share price; Precedent Transactions > Public Comps in valuation level, because of this premium.
Q: In a mixed consideration deal (50% cash, 50% acquirer shares), how do you calculate the total value paid and the implied multiple? What risk does this create for the seller?
A (summary): Transaction multiples use prices paid in real deals, so they capture control, synergies, and M&A cycle timing. For cash versus stock, I would calculate transaction value including equity purchase price, assumed debt, and adjustments, divided by normalized EBITDA or revenue. Key points: Document data limitations and outlier treatment.
Q: What is a control premium and why do M&A transactions typically result in higher multiples than trading comps?
A (summary): Control premium measures how much a buyer pays above the unaffected price to obtain control, synergies, and decision rights. For strategic premium, I would separate strategic premium, achievable synergies, and process competition. Key points: Document data limitations and outlier treatment.
Q: The target of a transaction reported EBITDA of R$300 million, but due diligence revealed R$80 million in adjustments. Which EBITDA do you use in the denominator of the transaction multiple?
A (summary): Transaction multiples use prices paid in real deals, so they capture control, synergies, and M&A cycle timing. For normalizing target EBITDA, I would calculate transaction value including equity purchase price, assumed debt, and adjustments, divided by normalized EBITDA or revenue. Key points: Document data limitations and outlier treatment.
Q: Why do analysts often use the 30- or 60-day VWAP as the basis for the premium paid instead of the price the day before announcement?
A (summary): Premium paid analysis compares offer price with unaffected price, VWAP, and periods before rumors. For 30-day VWAP, I would calculate premium over 1-day, 30-day, and 90-day prices, always checking leakage and liquidity. Key points: Document data limitations and outlier treatment.
Hard questions
Q: You are evaluating a transaction where the stock rose 12% in the 20 days before the announcement with no relevant public news. What does this suggest and how does it affect the premium calculation?
A (summary): Premium paid analysis compares offer price with unaffected price, VWAP, and periods before rumors. For leakage risk, I would calculate premium over 1-day, 30-day, and 90-day prices, always checking leakage and liquidity. Key points: Document data limitations and outlier treatment.
Q: How would you use precedent transactions in a cyclical sector without importing the wrong cycle into today’s valuation?
A (summary): Core principle: precedent transactions are useful only if they are re-anchored to the cycle phase in which they occurred. Mechanics: review normalized metrics at signing, commodity prices, spread conditions, and the strategic context of each deal. Key points: Re-anchor precedents to cycle context; Review market conditions for each deal; Avoid mechanically transporting multiples.
Q: Why do private equity funds generally pay smaller control premiums than strategic buyers? Under what circumstances would PE pay more?
A (summary): Financial buyer discount exists because sponsors usually lack the same operating synergies as strategic buyers and are constrained by IRR, leverage, and cost of debt. If a strategic buyer can cut R$50m of after-tax costs and capitalize that at 8x, it can justify up to R$400m of additional value. Key points: Sponsors are constrained by IRR and debt; Strategics can pay for operating synergies; High rates reduce ability to pay.
Q: In the CVM regulatory context, what is the mandatory tender offer upon change of control and how does it affect the implied control premium in Brazilian M&A transactions?
A (summary): Control premium measures how much a buyer pays above the unaffected price to obtain control, synergies, and decision rights. For Brazil tender offer, I would separate strategic premium, achievable synergies, and process competition. Key points: Document data limitations and outlier treatment.
Q: A strategic buyer estimates R$500 million in synergies. How does the negotiation typically split those synergies between buyer and seller, and how does that reflect in the premium paid?
A (summary): Control premium measures how much a buyer pays above the unaffected price to obtain control, synergies, and decision rights. For synergy sharing, I would separate strategic premium, achievable synergies, and process competition. Key points: Document data limitations and outlier treatment.
Q: A precedent transaction was completed after an auction process with six buyers. The current deal is an exclusive bilateral negotiation. How does process tension affect the premium's comparability?
A (summary): Deal comparability requires context, not just sector. For auction tension, I would compare size, control acquired, strategic versus financial buyer, geography, cycle, growth, margins, payment structure, and competitive tension. Key points: Document data limitations and outlier treatment.
Q: A transaction includes R$200 million in earnout contingent on two-year EBITDA targets. How do you include — or exclude — the earnout in the implied transaction multiple when building your precedent transactions set?
A (summary): Transaction multiples use prices paid in real deals, so they capture control, synergies, and M&A cycle timing. For earnout treatment, I would calculate transaction value including equity purchase price, assumed debt, and adjustments, divided by normalized EBITDA or revenue. Key points: Document data limitations and outlier treatment.
Q: You are using a 2021 transaction (peak of the commodity cycle) as a precedent for a 2024 deal (normalized cycle). How does the cycle timing affect the multiple's comparability?
A (summary): Deal comparability requires context, not just sector. For cycle timing, I would compare size, control acquired, strategic versus financial buyer, geography, cycle, growth, margins, payment structure, and competitive tension. Key points: Document data limitations and outlier treatment.
Q: A precedent transaction took 18 months for CADE approval and the acquirer made significant divestitures. How do you adjust that transaction's multiple to reflect regulatory risk?
A (summary): Deal comparability requires context, not just sector. For regulatory approval, I would compare size, control acquired, strategic versus financial buyer, geography, cycle, growth, margins, payment structure, and competitive tension. Key points: Document data limitations and outlier treatment.
Q: You have a precedent of a Brazilian company acquisition by a US buyer in 2022, when BRL was at R$5.20/USD. The current exchange rate is R$4.80. How does the FX effect affect the multiple's comparability in USD?
A (summary): Deal comparability requires context, not just sector. For cross-border FX, I would compare size, control acquired, strategic versus financial buyer, geography, cycle, growth, margins, payment structure, and competitive tension. Key points: Document data limitations and outlier treatment.
Expert questions
Q: One of your precedents involved a financially distressed seller who accepted a 30% discount to close quickly. How do you treat that deal in your precedent set — and what happens if it is the only relevant comparable?
A (summary): Deal comparability requires context, not just sector. For distressed seller, I would compare size, control acquired, strategic versus financial buyer, geography, cycle, growth, margins, payment structure, and competitive tension. Key points: Document data limitations and outlier treatment.
Q: You are advising a controlling shareholder who wants to delist a B3-listed company. The exit price for the minority squeeze-out must be justified with similar transaction precedents. What criteria do you use to select comparable deals and what minimum premium would you expect to defend before the CVM?
A (summary): Control premium measures how much a buyer pays above the unaffected price to obtain control, synergies, and decision rights. For minority squeeze-out, I would separate strategic premium, achievable synergies, and process competition. Key points: Document data limitations and outlier treatment.
Common mistakes
- Ignoring the control premium Transaction multiples include a premium for control and synergies. That's the main reason they sit above trading comps — say so explicitly.
- Using stale deals A transaction from a different rate or M&A environment can mislead. Weight recent, comparable deals and flag the ones you'd discount.
- Not adjusting for deal context A distressed sale and a competitive auction produce very different multiples. Name the process behind the headline number.
How to structure your answer
Open with the framework in one line, state your assumption, give the number or direction, then name the trade-off. Interviewers reward a thesis with a caveat over a confident monologue.
Defend it out loud.
Start a free mock and get structured feedback on these questions.
FAQ
More interview questions
Keep going: browse all resources